Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy

Mengxiao Wang,Huayan Huang,Zhangwendi Xu,Ziming Li,Lan Shen,Yongfeng Yu,Shun Lu

Lung Cancer（2022）

引用 1|浏览18

暂无评分

摘要

•Current HPD definitions failed to distinguish patients with worse survival.•Multiple new lesions is a risk factor for worse survival in PD patients.•Complementing HPD with new lesions could improve the prognostic value.

查看译文

关键词

Non-small cell lung cancer,Immunotherapy,Hyperprogression,New lesion

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要